Analysis | Metabolite Name | Measured Value | Units | Brain region | Age | Gender |
---|---|---|---|---|---|---|
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 1000 | Peak height | Hippocampus | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 1000 | Peak height | Hypothalamus | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 1000 | Peak height | Midbrain | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 1000 | Peak height | NA | NA | NA |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 1000 | Peak height | Olfactory bulb | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 1000 | Peak height | Olfactory bulb | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 1000 | Peak height | Thalamus | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 2689 | Peak height | Cerebellum | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 3308 | Peak height | Medulla | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 3416 | Peak height | Hypothalamus | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 3521 | Peak height | Cerebral cortex | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 3652 | Peak height | Thalamus | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 3663 | Peak height | Midbrain | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 4142 | Peak height | Hypothalamus | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 4173 | Peak height | Medulla | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 4195 | Peak height | Midbrain | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 4340 | Peak height | Hippocampus | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 5381 | Peak height | Hippocampus | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 6769 | Peak height | Olfactory bulb | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 6875 | Peak height | Medulla | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 7199 | Peak height | Pons | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 7702 | Peak height | Thalamus | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 7934 | Peak height | Pons | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 8705 | Peak height | Cerebral cortex | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 9083 | Peak height | NA | NA | NA |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 9149 | Peak height | Cerebral cortex | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 9202 | Peak height | Midbrain | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 9970 | Peak height | Pons | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 10748 | Peak height | Cerebellum | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 11295 | Peak height | Basal ganglia | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 11816 | Peak height | Pons | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 11843 | Peak height | Hypothalamus | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 13443 | Peak height | Cerebellum | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 13571 | Peak height | Thalamus | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 14076 | Peak height | Pons | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 14510 | Peak height | Medulla | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 14669 | Peak height | Medulla | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 14733 | Peak height | Cerebellum | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 14768 | Peak height | Midbrain | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 14771 | Peak height | Hippocampus | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 15470 | Peak height | Cerebellum | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 15583 | Peak height | Hippocampus | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 15944 | Peak height | Hippocampus | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 16037 | Peak height | Cerebellum | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 16936 | Peak height | Medulla | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 16982 | Peak height | Hypothalamus | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 17516 | Peak height | Basal ganglia | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 18067 | Peak height | Cerebellum | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 18106 | Peak height | Medulla | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 18402 | Peak height | Olfactory bulb | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 18606 | Peak height | Cerebellum | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 18609 | Peak height | Hypothalamus | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 19124 | Peak height | Medulla | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 19144 | Peak height | Olfactory bulb | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 20300 | Peak height | Midbrain | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 20920 | Peak height | Pons | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 20967 | Peak height | Pons | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 21070 | Peak height | Cerebellum | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 21117 | Peak height | Hippocampus | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 21163 | Peak height | Thalamus | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 21448 | Peak height | Hypothalamus | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 22046 | Peak height | Midbrain | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 22638 | Peak height | Midbrain | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 22998 | Peak height | Midbrain | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 23273 | Peak height | Olfactory bulb | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 24211 | Peak height | Pons | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 24636 | Peak height | Medulla | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 24638 | Peak height | Cerebellum | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 25125 | Peak height | Midbrain | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 25313 | Peak height | Cerebral cortex | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 25406 | Peak height | Midbrain | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 25833 | Peak height | Thalamus | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 25948 | Peak height | Cerebral cortex | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 26328 | Peak height | Midbrain | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 26459 | Peak height | Hippocampus | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 26766 | Peak height | Cerebellum | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 27026 | Peak height | Cerebellum | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 28127 | Peak height | Hippocampus | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 28496 | Peak height | Thalamus | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 29095 | Peak height | Midbrain | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 29351 | Peak height | Hippocampus | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 29657 | Peak height | Basal ganglia | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 30208 | Peak height | Olfactory bulb | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 30571 | Peak height | Medulla | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 30589 | Peak height | Hypothalamus | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 30932 | Peak height | Hippocampus | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 31365 | Peak height | Cerebral cortex | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 31501 | Peak height | Hippocampus | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 31608 | Peak height | Basal ganglia | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 31679 | Peak height | Olfactory bulb | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 32453 | Peak height | Cerebral cortex | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 32524 | Peak height | Basal ganglia | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 32536 | Peak height | Pons | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 32678 | Peak height | Cerebral cortex | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 32825 | Peak height | Pons | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 32879 | Peak height | Olfactory bulb | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 33923 | Peak height | Olfactory bulb | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 35230 | Peak height | Pons | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 35399 | Peak height | Cerebellum | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 35466 | Peak height | Hypothalamus | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 35476 | Peak height | Olfactory bulb | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 35521 | Peak height | Hippocampus | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 36267 | Peak height | Cerebral cortex | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 37345 | Peak height | Medulla | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 37365 | Peak height | Olfactory bulb | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 37610 | Peak height | Medulla | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 38476 | Peak height | Cerebral cortex | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 38962 | Peak height | Midbrain | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 39132 | Peak height | Pons | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 40127 | Peak height | Olfactory bulb | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 40256 | Peak height | Midbrain | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 40458 | Peak height | Medulla | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 41445 | Peak height | Basal ganglia | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 41771 | Peak height | Medulla | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 42276 | Peak height | Thalamus | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 42659 | Peak height | Pons | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 42924 | Peak height | Pons | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 43041 | Peak height | Cerebellum | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 43512 | Peak height | Cerebral cortex | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 43590 | Peak height | Basal ganglia | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 43710 | Peak height | Hypothalamus | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 43890 | Peak height | Hippocampus | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 44025 | Peak height | Olfactory bulb | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 44249 | Peak height | NA | NA | NA |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 44733 | Peak height | Cerebral cortex | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 45201 | Peak height | Midbrain | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 45263 | Peak height | Basal ganglia | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 46704 | Peak height | NA | NA | NA |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 47134 | Peak height | Basal ganglia | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 47305 | Peak height | Basal ganglia | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 47750 | Peak height | NA | NA | NA |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 48300 | Peak height | NA | NA | NA |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 48311 | Peak height | Medulla | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 48320 | Peak height | Cerebellum | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 49274 | Peak height | Hippocampus | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 49364 | Peak height | Basal ganglia | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 49389 | Peak height | Basal ganglia | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 49877 | Peak height | Midbrain | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 50058 | Peak height | Midbrain | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 50095 | Peak height | Cerebral cortex | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 50166 | Peak height | Basal ganglia | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 51146 | Peak height | NA | NA | NA |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 51291 | Peak height | Medulla | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 51609 | Peak height | Basal ganglia | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 52081 | Peak height | Pons | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 53131 | Peak height | Cerebral cortex | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 53600 | Peak height | Hypothalamus | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 54241 | Peak height | Hypothalamus | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 54628 | Peak height | Cerebellum | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 54635 | Peak height | Thalamus | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 55092 | Peak height | Hypothalamus | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 55309 | Peak height | Pons | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 55325 | Peak height | Midbrain | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 55331 | Peak height | Medulla | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 55688 | Peak height | Cerebral cortex | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 55790 | Peak height | Midbrain | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 56217 | Peak height | Medulla | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 56951 | Peak height | Midbrain | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 57286 | Peak height | Midbrain | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 57632 | Peak height | Olfactory bulb | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 57684 | Peak height | Midbrain | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 58010 | Peak height | Olfactory bulb | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 58362 | Peak height | Olfactory bulb | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 59236 | Peak height | Cerebral cortex | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 59292 | Peak height | Cerebellum | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 59319 | Peak height | Medulla | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 59593 | Peak height | Medulla | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 59935 | Peak height | Olfactory bulb | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 60864 | Peak height | Cerebellum | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 60904 | Peak height | Thalamus | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 61384 | Peak height | Medulla | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 61401 | Peak height | Basal ganglia | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 61518 | Peak height | Cerebellum | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 61565 | Peak height | Cerebral cortex | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 61575 | Peak height | Hypothalamus | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 62239 | Peak height | Basal ganglia | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 62321 | Peak height | Pons | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 62954 | Peak height | Hippocampus | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 63700 | Peak height | Cerebral cortex | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 64298 | Peak height | Midbrain | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 64683 | Peak height | Cerebral cortex | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 66371 | Peak height | Medulla | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 67788 | Peak height | Medulla | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 68200 | Peak height | Cerebellum | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 68283 | Peak height | Cerebral cortex | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 68942 | Peak height | Medulla | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 69093 | Peak height | Hippocampus | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 69244 | Peak height | Hypothalamus | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 69261 | Peak height | Pons | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 69376 | Peak height | Midbrain | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 70145 | Peak height | Cerebral cortex | 3 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 70590 | Peak height | Cerebral cortex | 59 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 71195 | Peak height | Olfactory bulb | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 71249 | Peak height | Olfactory bulb | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 71400 | Peak height | Hypothalamus | 3 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 71507 | Peak height | Hippocampus | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 71731 | Peak height | Medulla | 16 weeks | Female |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 72540 | Peak height | Pons | 59 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 73151 | Peak height | Hypothalamus | 16 weeks | Male |
HILIC POSITIVE ION MODE | 5β-Androstane-3α,17β-diol | 73267 | Peak height | Cerebellum | 3 weeks | Male |
Return to search page